Status:
COMPLETED
Study Using Induction Chemotherapy and Intensity-Modulated Radiation Therapy Guided by Combined CT and PET Imaging for Patients With Non-Small Cell Lung Cancer
Lead Sponsor:
Alberta Health services
Conditions:
Carcinoma, Non-Small-Cell Lung
Eligibility:
All Genders
18+ years
Phase:
PHASE1
PHASE2
Brief Summary
Lung cancer is the leading cause of cancer-related mortality in the United States (US) and Canada. Because of the high incidence and mortality of this disease, small improvements in the management of ...
Detailed Description
Hypothesis and Objectives: The hypothesis that respiratory gated IMRT can escalate safely radiation doses for NSCLC with induction chemotherapy will be tested. The intent of the study is to determine ...
Eligibility Criteria
Inclusion
- Stage I-III
- Unresectable non-small cell lung cancer (NSCLC)
- EEV1 equal to or greater than 1.0L
Exclusion
- Positive supraclavicular noce (N2) or malignant pleural effusion
Key Trial Info
Start Date :
September 1 2003
Trial Type :
INTERVENTIONAL
End Date :
August 1 2007
Estimated Enrollment :
5 Patients enrolled
Trial Details
Trial ID
NCT00128999
Start Date
September 1 2003
End Date
August 1 2007
Last Update
February 9 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Cross Cancer Institute
Edmonton, Alberta, Canada, T6G 1V2